LKEQX
Price
$36.06
Change
+$0.14 (+0.39%)
Updated
May 13 closing price
Net Assets
480.38M
RGEBX
Price
$73.05
Change
+$0.91 (+1.26%)
Updated
May 13 closing price
Net Assets
296.3B
Ad is loading...

LKEQX vs RGEBX

Header iconLKEQX vs RGEBX Comparison
Open Charts LKEQX vs RGEBXBanner chart's image
LKCM Equity
Price$36.06
Change+$0.14 (+0.39%)
VolumeN/A
Net Assets480.38M
American Funds Growth Fund of Amer R2E
Price$73.05
Change+$0.91 (+1.26%)
VolumeN/A
Net Assets296.3B
LKEQX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LKEQX vs. RGEBX commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LKEQX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 296B vs. LKEQX (480M). LKEQX pays higher dividends than RGEBX: LKEQX (0.53) vs RGEBX (0.00). LKEQX was incepted earlier than RGEBX: LKEQX (29 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LKEQX (0.98). RGEBX is a more actively managed with annual turnover of: 25.00 vs. LKEQX (9.00). RGEBX has a lower initial minimum investment than LKEQX: RGEBX (250) vs LKEQX (2000). RGEBX annual gain was more profitable for investors over the last year : 7.82 vs. LKEQX (-5.10). RGEBX return over 5 years is better than : 50.30 vs. LKEQX (35.44).
LKEQXRGEBXLKEQX / RGEBX
Total Expense Ratio0.801.0973%
Annual Report Gross Expense Ratio0.981.0990%
Fund Existence29 years11 years-
Gain YTD-5.4502.254-242%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets480M296B0%
Annual Yield % from dividends0.530.00-
Returns for 1 year-5.107.82-65%
Returns for 3 years7.1935.3920%
Returns for 5 years35.4450.3070%
Returns for 10 years54.6561.1589%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXBR2.040.39
+23.64%
Oxbridge Re Holdings Limited
SAMG14.790.35
+2.42%
Silvercrest Asset Management Group
PENN16.160.19
+1.19%
PENN Entertainment
RPRX32.82-0.53
-1.59%
Royalty Pharma plc
TRVI6.45-0.24
-3.66%
Trevi Therapeutics